Author: FOCM Networking

Entering Possibly Humorous Zone

So I don’t know how or why, probably genetics has a lot to do with it, I take a light-hearted approach to life and look to find the humor in things or just make up the humor. Peter Holthe, the driving force that made FOCM happen, called me irreverent. Having just looked it up, it means: showing a lack of respect for people or things that are generally taken seriously. I don’t intend to show a lack of respect but I like humor more than seriousness. Of course there’s a time and a place for both. But funny observations are always just under the serious stuff for me.

So my twin brother recently must have been surfing the web, maybe Wikipedia and spent time on the origin of the names of a couple of America’s states: Idaho and Texas. Below will be what he wrote and what I replied with.

My brother sent this: The name “Idaho” has no translation at all because it’s entirely made up. In an early form of marketing that would make these modern-day businesses proud, the name was suggested by a local leader in 1860 who claimed the word “Idaho” was a Native American word for “gem of the mountains.” Later that same year, gold was discovered in the Clearwater area, proving his invented name wasn’t far off base.

To which I replied: That’s close to accurate.  It was made up, but it was “Idano” and a typesetting issue on the old printing press mistakenly set the n as an h.  Quite easy to do as they are close to each other. The name “Idano” was because when others heading west asked the people in what is now Idaho, why they stopped there and didn’t go any further, their answer was “idano”.

Then he sent this about Texas: Like the Dakotas, Texas was named with friendship in mind. Texas is a variant of a word (Teysha) used by some Native Americans to refer to friends or allies. It has many different spellings, including “Texias,” “Tejas,” and “Teysas.”

To which I replied: A variant book of name origins reveals this: Like the Carolinas, Texas was named after a particular member of the royal family, albeit, for Texas, it was a lesser known Earl of a small, rural Scottish Isle.  His name was Tex, Earl of the Isle of Mull.  Tex was rather eccentric and thought being Earl meant he was King of his Isle.  When people would see something new or different on the isle, they’d ask “whose is that?” The answer was always “it’s Tex’s”.  Tex did little actual work and spent a lot of time thinking – coincidentally Tex is the reason that to “mull” it over means to think on something.  Tex’s incompetency lead to his eventual over throw and he was sent to the new colonies. He eventually settled in what is now Odessa. He got very active in the public square where his eccentricities and overblown ego eventually resulted in the state being named Texas.

FOCM Network Brainstorming Project

A friend and FOCM member in good standing is starting her consultancy company and is looking to find a good and proper name. As an annual dues paying member, she is entitled to this calling forth the idea generation of the FOCM Network.

The option to name it something like: lastname (use Smith as the example) consulting, of course is an option. I proposed we ask this network to do some thinking and see if we could come up with a name that will communicate what it is she can best contribute.

So here’s the background info:
This individual has over 25 years experience as a Clinical Research Scientist, Director of Clinical Operations, Executive Director and VP of Strategic Programs, Alliances and Governance. The past 12 years have been in the area of managing strategic accounts and partnership governance. This is a particularly strong area of expertise and focus.

Let’s use the normal brainstorming rules – no idea is a bad idea, don’t shoot down any other ideas – just want to generate name ideas. I’ll get it started:

CRO/Bio/Pharm Alliance Management, LLC
Alliance Governance, LLC
Clinical Research Partnership Governance, LLC
Smith Consulting, LLC
Clinical Research Alliance Governance, LLC
Clinical Research and Governance, LLC
Strategic Governance, LLC

Reply in comments with your quick, off the top of your head ideas. Many thanks.

New FOCM Member

On June 28, 2019 while attending the annual Drug Information Association (DIA) meeting in San Diego, FOCM was busy expanding its network. All new membership ceremonies are significant and strict adherence to protocol is (almost) always followed. This particular ceremony included a new addition to the protocol. FOCM is pleased to announce that Jodi Andrews, Founder and Co-CEO of Pro-Trials Research received her membership card.

This ceremony took place on the exhibit hall floor. What was added to the procedure for this ceremony was a shot of bourbon prior to the handshake, card presentation and photo. Later, a small pour of Fireball was distributed to the new member.

The Power of Words on Performance

Over the years, I have read a lot of self-help books, listened to tapes and podcasts.  At this point in my career, I thought I didn’t need to read those any more as, at this point, I am who I am. 

Reading this article reminded me that there is much value in the attitude and approach of continually learning.  As my friend, Martin Cleary has said repeatedly: be in knowledge acquisition mode.  This article also reinforces the power of words on personal actions.  Jeff Haden is the author. https://www.inc.com/jeff-haden/stop-using-i-start-using-this-word-instead-you-can-improve-performance-reduce-stress-increase-your-willpower-endurance.html?cid=landermore

I recommend you read the entire article.  I’ve briefly selected a couple of simple yet powerful points:

Research has proven that some forms of self-talk are effective.  For example there is a difference between saying “I can’t,” and, “I don’t,” to yourself.

One group was given a simple temptation and told to say, when tempted, “I can’t do (that).” The other group was told to say, “I don’t do (that).” 

Here’s what happened: 

  • Participants told to say “I can’t” gave in to the temptation 61 percent of the time.
  • Participants told to say “I don’t” gave in to the temptation 36 percent of the time.

Simply switching one word, “don’t” for “can’t,” made participants twice as likely to stay the course.

Then the researchers conducted a second experiment: Participants were told to set a personal long-term health and wellness goal. When their initial motivation waned — as initial motivation always tends to do — one group was told to say, “I can’t miss my workout.” A second group was told to say, “I don’t miss my workouts.” The third group, the control group, wasn’t given a temptation-avoidance strategy. 

After 10 days: 

  • 3 out of 10 control group members stuck to their goal.
  • 1 out of 10 “I can’t” group members stuck to their goal.
  • 8 out of 10 “I don’t” group members stuck to their goal.

Not only was “I can’t” less effective than “I don’t”; “I can’t” was less effective than using no strategy at all. 

According to the researchers:

‘I don’t’ is more persuasive than ‘I can’t’ because the former connotes conviction to a higher degree.

Or in non researcher-speak, saying “I can’t,” leads to negotiating with yourself. “I can’t have dessert… but then again, if I work out later… or if I skip breakfast tomorrow…”

Once you start to negotiate with yourself, you need willpower to win that argument.

But “I don’t” leaves no room for argument. “I don’t” doesn’t reflect a choice; it states who you are.

One word makes a huge difference.

Especially when that word is a pronoun.

The Power of “You”…

Science shows the difference between using “I” and “you” when you talk to yourself can be dramatic. 

Take public speaking: Research shows that second-person self-talk — saying “You can do this” to yourself instead of “I can do this” – will improve your performance.

And then there’s this: Swapping “you” for “I” can also improve your willpower and endurance. Researchers had participants do a number of 10k cycling time trials. After a baseline was established, researchers encouraged them to frame their self-talk differently.

  • Replacing “I need to keep going” with “You can keep going.”
  • Replacing “No pain, no gain” with “You can work through the pain.”
  • Replacing “I can do this” with “You can do this.”

While the differences seem insignificant, the results were not: 13 out of 16 participants rode faster, and the average person’s time improved by 2.4%. 

Just by saying “you” instead of “I.”

FOCM Member Displays Membership Pin

On June 11, 2019 in RTP, NC I attended Heather Hollick’s book release event. Heather wrote a book on networking, entitled Helpful: A Guide to Life, Careers and the Art of Networking. I was introduced to Heather by Tanyss Mason. It was Christine Sears who recommended Tanyss get in touch with me when she was undertaking a job search. Heather and I clicked immediately over a phone call on our mutual view of networking.

Helpful

The book release event was held at the NC Biotech Center. I promoted this event to the FOCM network. Five members joined the approximately 40 others. I was pleased to see member Peter Benton in attendance. As I walked over to say hi, he pointed out that he was wearing his FOCM membership pin. Peter thought FOCM should have some kind of salute, the three finger salute isn’t going to be it, but it was a good attempt on short notice.

Peter Benton FOCM Pin

Benefits of Capitalism in Drug Discovery

Nathan Yates has spinal muscular atrophy and is a professor or economics and finance. Here’s an excerpt of his article on the price of a new drug to treat his condition. The bold in the text below is mine. The

The full article is here:
https://www.statnews.com/2019/05/31/spinal-muscular-atrophy-zolgensma-price-critics/

As someone who has lived with spinal muscular atrophy for all 30 years of my life, I was perplexed and disappointed that the recent approval of Novartis’ gene therapy Zolgensma was immediately overshadowed by outrage over the drug’s price: $2.125 million.

The Food and Drug Administration’s decision was a pivotal day for those of us in the SMA community. Zolgensma, approved for children under 2, is the only one-dose treatment option for any category of SMA patients and has been highly effective in clinical testing so far.

Sure, it’s the world’s priciest drug. But instead of debating the level of financial profit that is appropriate for Novartis, let’s focus on the needs of patients. How are we going to get treatments for rare diseases if there’s not a financial incentive for doing it? Therapies are being developed because people think they can sell them for a profit. We don’t like to talk about it, but pharmaceutical companies exist to make money. Don’t we realize, though, that all of society profits from each disease we cure and each baby that is saved from SMA and other deadly diseases?

As a professor of economics and finance, I believe that the cost-related complaints being thrown around social media are short-sighted. Shortly after Zolgensma’s price was announced, I even told a friend, “This is a good problem to have.” Why? It’s a twofold answer:

  1. Competition – drives cost down
  2. Long term value – each successive drug that’s approved will be an improvement – whether that’s injected by IV once instead of into the spinal column every 4 months or made into a pill for once a day dosing. drug

Biostatistics Job Openings

Array Biostatistics is hiring for multiple Biostatistician and Statistical Programming positions. Preferred location is Wilmington, NC or RTP, NC but are open to remote locations depending on the candidate’s experience.

For more information or to apply go to this link or reach out to me at chris@focmnetworking.com

Jobs

Job Opening: Program Manager, Patient Affordability

FOCM is helping a member of the network fill a job opening. Please contact me if you want more details and share this with others who you know may be interested.

As a Program Manager, you will help eliminate barriers for patients, increase their access to medications, and help them receive lifesaving treatments while working in an environment that nurtures you.

The Program Manager (PM), as the primary business relationship manager, is responsible for program management, account management, financial management and business analysis.

The PM will be responsible for providing excellent customer service, exceptional program management, in-depth program knowledge and operational excellence for their assigned brands. As the primary point of contact between our valued customers and Company, the PM serves a crucial role in driving internal project teams to deliver Company’s full suite of products and services on schedule, on budget, and within scope.

The ideal candidate must be a self-starter, high performer and able to embrace change in order to adapt within a fast growing organization.

Qualifications

  • Bachelor’s degree with a concentration in business, accounting, marketing and/or healthcare, or pharmaceutical industry, graduate degree and/or additional certifications including PMP preferred
  • Three to four (3-4) years of project or program management experience

Essential Skills Training

On March 23, 2019 at UNC-Wilmington (UNCW) Fuse CR site, a 6 hour workshop on Essential Skills was held. I’d gotten involved with this initiative through my desire to use my network to help others.

FuseCR (Center for Clinical Research Workforce Development) is a collaborative designed to ignite a new synergy between UNCW and the field of clinical research. By fusing resources and knowledge from academia and industry, FuseCR is energizing the local clinical research talent with powerful career and industry enhancing services.

Working with Tiffany Erichsen and Susan Sinclair, we put on a program for the students in the Bachelor’s and Master’s Degrees in Clinical Research.

The first topic was Effective Leadership Styles presented by Michael Williams. Michael is the Chief Executive Director of the Executive Service Corps of the Triangle. I’ve known Michael for over 30 years. We were room-mates while in training for our first jobs out of college with Burroughs Wellcome Co. He is an excellent presenter. Students learned the DISC profile and its role in leadership and communications.

The second topic was Collaborative Negotiating presented by Jim Sheegog. Jim is a founder of Rowhill Consulting Group. Jim and I have known each other around 20 years. Jim also worked at Burroughs Wellcome Co which is where we met and then by chance I ran into him at a local restaurant about 7 years ago. Jim is well known in the corporate training and leadership development industry with significant work at global organizations.

A representative from the UNCW Career center spoke over lunch regarding professionalism, conference attendance, image and how to navigate a buffet lunch.

The final speaker was Danielle Baxter and she spoke on Branding. Danielle is Director of Business Development for Paragon Global CRS. I’ve known Danielle for 2 years and she is a very impressive speaker.

I was able to help because I keep in touch with people I’ve met from across the spectrum of my career and I put in effort to maintain the relationship – networking.

Leadership Styles
Leadership Workshop
Collaborative Negotiation
Branding

New FOCM Member

While attending SCOPE in mid-February in Orlando, I had the good fortune of welcoming Marie Perrone into FOCM. I had met Marie several years before via an introduction by long-time FOCM member, friend and former co-worker, Deb Nichols. It took so long for Marie to get her card due to some strange, but ultimately explainable issues in the background check that is run on all FOCM member candidates. The joy of receiving her card and the overwhelming relief to have resolved the items of her past is quite evident in the photo of this memorable event.

Marie Perrone receives her FOCM Membership card
Photo taken by Deb Nichols